Le Lézard
Classified in: Health
Subjects: HSP, ASI, BLK, NTA, DEI

Civicom® Webinar with Zebra Strategies: Spotlighting the Disparities in Infant Health Present in BlPOC Communities


GREENWICH, Conn., April 12, 2021 /PRNewswire-PRWeb/ -- Civicom®, the trusted market research services provider of web-enabled IDIs and focus groups, is hosting a joint webinar with Zebra Strategies on Giving Voice To Disparities in Infant Health in BIPOC Communities Through Web-Enabled Interviews. Leading the charge will be Sharon Arthur, Director of Brand Management for Zebra Strategies, and Stan Satty, a Global Account Manager with Civicom® Marketing Research Services. The webinar will take place on the 14th of April from 1:00 PM to 1:45 PM EST.

Zebra Strategies, with support from Civicom® Marketing Research Services, will explore how cultural beliefs, socio-economic factors, implicit bias, and structural racism factor into the higher rates of Sudden Unexpected Infant Death Syndrome ("SUID") experienced by BIPOC communities. Also known as the Sudden Infant Death Syndrome or SIDS, SUID is defined as the sudden and unexplained death of a baby younger than 1-year-old with relevant causes often hard to determine. The webinar will provide attendees a closer look at the processes and challenges that led to the collaborative success of the study using the Civicom platform CyberFacility®.

Civicom CyberFacility®, a telephone and web-enabled interview and focus group solution, was crucial in making it possible to interview difficult to reach respondents from underserved communities through the use of webcam interviews and mobile devices. Sharon Arthur will share how Civicom® technology and support services enabled Zebra Strategies to hold these in-depth interviews, which gave voice to the issues faced by the participants and uncovered insights on the dynamics of infant health in BIPOC communities.

Click here to register.

About Civicom® Marketing Research Services

Civicom® Marketing Research Services offers many options to enhance the research process for marketing research professionals. Civicom® is the global leader in facilitating telephone and web-enabled in-depth interviews and focus groups using Civicom CyberFacility®. Civicom® also offers Civicom Chatterbox®, an asynchronous research platform for online communities and bulletin boards, plus the Civicom ThoughtLight® Mobile Insights App, a mobile qualitative tool for collecting richer in-the-moment insights, useful for shopper insights, audio diaries, and patient journeys.

Civicom® operates in over 96 countries and offers extensive translation services for marketing researchers, as well as transcription services through TranscriptionWingtm, and market research respondent recruiting through CiviSelecttm. All of these services are available in Spanish, as well as English, and multiple other languages.

Civicom® Marketing Research Services chooses to be as dynamic as it is innovative; always listening to and acting on clients' ideas and requests as they see fit. This kind of relationship has paved the way for the development and roll-out of new services. To learn more, email Civicom® at inquire(at)civicommrs(dot)com or call +1-203-413-2423.

Media Contact

Rebecca West, Civicom Marketing Research Services, +1-203-413-2423, [email protected]

Twitter

 

SOURCE Civicom Marketing Research Services


These press releases may also interest you

at 22:00
Frost & Sullivan recently analyzed the hospital industry and noted that operational inefficiencies, workflow interruptions and shortage of skilled healthcare professionals are some key challenges faced by the healthcare industry. Based on its...

at 20:14
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 19:30
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against agilon health, inc. ("agilon" or the "Company").  This action, captioned Hope v. agilon health, inc., et...

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...



News published on and distributed by: